Immune-Onc Therapeutics has signed an exclusive license and collaboration agreement with The University of Texas Health Science Center at Houston (“UTHealth”) and The University of Texas Southwestern Medical Center (“UTSW”), two member institutions of The University of Texas System (“UT System”).
News from Twitter
Teva deals Paragard IUD assets to Cooper Cos. for $1B captis.com/?p=34209
NuVasive launches LessRay radiation-reducing surgical software captis.com/?p=34204
CMS alerts physicians of payment reductions for PQRS noncompliance bit.ly/2wGEkx3
Zip Surgical Skin Closure Reduces PostDischarge Costs Clinic Calls and Antibiotics in First Economic Study of D... ow.ly/I0CI50e6sbq
Looking forward to meeting you all at #BIO2017 San Diego, June 19-22, 2017. Let's schedule: 1 (800) 445-1839 // +41 22 518 2100
Scopis launches mixed reality spinal surgery navigator with Microsoft’s HoloLens captis.com/scopis-la…
One Drop, MannKind ink partnership for connected, inhaled diabetes tech captis.com/?p=33587
Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News